drugset / Trial / NCT06407973

A Clinical Trial Comparing the OMNI Surgical System to Standard Medical Treatment in Patients With Primary Open Angle Glaucoma

NCT06407973

Phase 4 Terminated 2 enrolled Sight Sciences, Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

A Randomized Clinical Trial of Ab Interno Canaloplasty and Trabeculotomy with the OMNI® Surgical System Compared to Standard Medical Treatment as a Standalone Procedure in Patients with Primary Open Angle Glaucoma (EVOLVE)

Timeline

Start
2024-08-21
Primary completion
2025-01-20
Completion
2025-01-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Latanoprost Small molecule 0.005 % Topical

Indications